Cycore Helps Home Intelligence Platform, Cocoon, Achieve 100% SOC 2 Type 2 Compliance in Three Weeks
Miami-based cybersecurity firm steps in mid-observation period to close compliance gaps and keep a critical certification on track. MIAMI, April 6, 2026 /PRNewswire/... Read more.
Clear Channel Outdoor Holdings, Inc. Commences Consent Solicitation Relating to its Senior Secured Notes
SAN ANTONIO, April 6, 2026 /PRNewswire/ — Clear Channel Outdoor Holdings, Inc. (“Clear Channel” or the “Company“) (NYSE: CCO) announced... Read more.
Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio
VYKAT™ XR (diazoxide choline) is the First and Only FDA Approved Treatment for Hyperphagia in Prader-Willi Syndrome and Represents a Transformative Therapy Expands... Read more.
Scinai Completes Strategic Reorganization to Establish Dedicated CDMO Platform and Lean R&D Structure; Outlines 2026 Priorities
JERUSALEM, April 6, 2026 /PRNewswire/ — Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI); (“Scinai” or the “Company”), a biopharmaceutical... Read more.
Miami International Holdings Reports Trading Results for March 2026
MIAX Exchange Group reports 26.6% increase in multi-list options YTD ADV PRINCETON, N.J. and MIAMI, April 6, 2026 /PRNewswire/ — Miami International Holdings,... Read more.
Epson RapidReceipt RR-600W Document Scanner Named a Good Housekeeping 2026 Cleaning Awards Winner
RapidReceipt Sets up Home Offices for Success, Turning Household Paperwork into Smart Digital Assets for Today’s AI Workflows LOS ALAMITOS, Calif., April 6,... Read more.
17TRACK: USPS Tracking Changes Signal Shift Toward Accountable Access
BREA, Calif., April 6, 2026 /PRNewswire/ — As the United States Postal Service (USPS) prepares to introduce new tracking access controls on April 1, 2026,... Read more.
DataBeyond Unveils Asia’s Largest Unmanned AI Sorting Center, Setting a New Circular Economy Benchmark
TAICHUNG, April 6, 2026 /PRNewswire/ — DataBeyond, a global leader in AI-powered intelligent sorting equipment, recently revealed that its flagship project... Read more.
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Trial of IDE574, a Potential First-In Class Dual Inhibitor of KAT6/7 to Target Multiple Solid Tumor Indications, including Breast, Prostate, CRC, and Lung Cancer
Potential first-in-class and selective equipotent dual inhibitor of KAT6/7 with single-digit to low teens nano-molar cellular potency in target engagement assays... Read more.
KuCoin Introduces PROOF, a Trading Competition Focused on Verifiability and Fair Play
PROVIDENCIALES, Turks and Caicos Islands, April 6, 2026 /PRNewswire/ — KuCoin, a leading global crypto platform built on trust, today announced the launch... Read more.